Gewählte Publikation:
Cerwenka, H; Aigner, R; Quehenberger, F; Werkgartner, G; Bacher, H; Hauser, H; Mischinger, HJ.
Preoperative differential diagnosis of benign and malignant pancreatic lesions--the value of pancreatic secretory trypsin inhibitor, procarboxypeptidase B, CA19-9 and CEA.
Hepatogastroenterology. 1997; 44(16):1117-1121
Web of Science
PubMed
Google Scholar
- Führende Autor*innen der Med Uni Graz
-
Cerwenka Herwig
- Co-Autor*innen der Med Uni Graz
-
Aigner Reingard
-
Bacher Heinz
-
Hauser Hubert
-
Mischinger Hans-Jörg
-
Quehenberger Franz
-
Werkgartner Georg
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Find related publications in this database (using NLM MeSH Indexing)
-
Adult -
-
Aged -
-
Aged, 80 and over -
-
CA-19-9 Antigen - blood
-
Carboxypeptidase B -
-
Carboxypeptidases - blood
-
Carcinoembryonic Antigen - blood
-
Diagnosis, Differential -
-
Enzyme Precursors - blood
-
Female -
-
Humans -
-
Male -
-
Middle Aged -
-
Pancreatic Diseases - blood Pancreatic Diseases - diagnosis
-
Pancreatic Neoplasms - blood Pancreatic Neoplasms - diagnosis
-
Preoperative Care -
-
Prospective Studies -
-
Radioimmunoassay -
-
Trypsin Inhibitor, Kazal Pancreatic - blood
-
Tumor Markers, Biological - blood